Results 161 to 170 of about 918,355 (214)
Some of the next articles are maybe not open access.
CNS Drugs, 2004
A controlled-release (CR) formulation of the SSRI paroxetine has been developed. This CR formulation delays the release of paroxetine until the tablet has passed through the stomach; the drug is then released over 4-5 hours. In well designed placebo-controlled trials in patients with major depressive disorder (including a study in the elderly), social ...
Lynne M, Bang, Gillian M, Keating
openaire +2 more sources
A controlled-release (CR) formulation of the SSRI paroxetine has been developed. This CR formulation delays the release of paroxetine until the tablet has passed through the stomach; the drug is then released over 4-5 hours. In well designed placebo-controlled trials in patients with major depressive disorder (including a study in the elderly), social ...
Lynne M, Bang, Gillian M, Keating
openaire +2 more sources
American Journal of Cardiovascular Drugs, 2008
▴ A new once-daily controlled-release (CR) capsule formulation of the nonselective β- and α1-adrenoceptor antagonist carvedilol is now available for use in the treatment of essential hypertension, heart failure (HF), and left ventricular dysfunction following myocardial infarction (MI).
Natalie J, Carter, Gillian M, Keating
openaire +2 more sources
▴ A new once-daily controlled-release (CR) capsule formulation of the nonselective β- and α1-adrenoceptor antagonist carvedilol is now available for use in the treatment of essential hypertension, heart failure (HF), and left ventricular dysfunction following myocardial infarction (MI).
Natalie J, Carter, Gillian M, Keating
openaire +2 more sources
Steroid control of gonadotropin release
Journal of Steroid Biochemistry, 1975Abstract Several studies have led to the concept that the length of the rat estrous cycle is dependent on the timing of estrogen (E) secretion. According to this hypothesis E secretion during the 5-day cycle is delayed. However, we have found LH and E levels in both 4 and 5 day cycles are identical.
L G, Nequin, J, Alvarez, N B, Schwartz
openaire +2 more sources
The American Journal of Medicine, 1973
Abstract There is evidence for two intrarenal receptors in the control of renin release. The renal vascular receptor appears to be located in the renal afferent arterioles in the region of the juxtaglomerular cells and to respond to changes in wall tension.
openaire +2 more sources
Abstract There is evidence for two intrarenal receptors in the control of renin release. The renal vascular receptor appears to be located in the renal afferent arterioles in the region of the juxtaglomerular cells and to respond to changes in wall tension.
openaire +2 more sources
On the Control of Renin Release
Nephron, 2008The role of carotid, aortic and cardiopulmonary receptors and of prostaglandins in the control of renin release was reviewed. It is suggested that the receptors in the low- and high-pressure circuits of the cardiovascular system control renin release through the renal sympathetic nerves and adrenal medulla. It is also suggested that prostaglandins play
openaire +2 more sources
Controlling cavitation for controlled release
2009 IEEE International Ultrasonics Symposium, 2009We present a novel, long-lived ultrasound contrast vehicle with triggered drug release capability. The vehicle comprises shell-stabilized microbubbles encapsulated within the aqueous core of a vesicle-like microcapsule. Encapsulating microbubbles enhances their longevity as ultrasound contrast agents by shielding the microbubbles from dissolution in a ...
Steven Wrenn +3 more
openaire +1 more source
Workload Control with continuous release
2009 IEEE International Conference on Industrial Engineering and Engineering Management, 2009Workload Control (WLC) is a production planning and control concept which is suitable for the needs of make-to-order job shops. Release decisions based on the workload norms form the core of the concept. This paper develops continuous time WLC release variants and investigates their due date performance in a simulation study. The results indicate that -
Phan, B. S. Nguyen +2 more
openaire +2 more sources
Adrenergic Control of Somatostatin Release*
Endocrinology, 1982The effects of adrenergic stimulation and suppression on somatostatin (SS), insulin, and glucagon release were studied in intact dogs. Isoproterenol, a beta-adrenergic agonist, significantly increased portal venous and arterial levels of SS and arterial levels of insulin and glucagon.
G, Boden +5 more
openaire +2 more sources
Controlled Release With Emphasis on Ultrasound-Induced Release
2018Mesoporous silica nanoparticles (MSNs) represent a promising approach to be used as nanocarriers because they fulfill some basic criteria: biocompatibility, high loading capacity and possibility of easy surface modifications. As a consequence, MSNs have been employed to design sophisticated stimuli-responsive nanocarriers able to release the entrapped ...
Maria, Vallet-Regi +2 more
openaire +2 more sources
Controlled Release of Microquantities of Macromolecules
Cancer Drug Delivery, 1984A technique for insuring the controlled release of small amounts of macromolecules such as polypeptides from polymeric delivery systems is described. We show that incorporation of albumin in milligram quantities into these delivery systems can facilitate the sustained release of nanogram or microgram quantities of a model macromolecule such as inulin ...
J, Murray, L, Brown, R, Langer
openaire +2 more sources